Lusutrombopag




Lusutrombopag Overview

Lusutrombopag, sold under the brand name Mulpleta among others, is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts) such as thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures. It is being manufactured and marketed in Japan by Shionogi.[1][2][3] It was approved by the U.S. Food and Drug Administration (FDA) in July 2018,...

Read more Lusutrombopag Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lusutrombopag

Recent Lusutrombopag Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lusutrombopag
  • Tablet: 3mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Lusutrombopag or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 3 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA